Virtual: Keys To Accessible Cytology Screening: How AI Is Bridging the Gap (Zoetis)

Virtual: Keys To Accessible Cytology Screening: How AI Is Bridging the Gap (Zoetis)

Sunday, January 18, 2026 3:00 PM to 3:25 PM · 25 min. (America/New_York)
VMX Virtual
Streaming - Virtual

Information

Explore the impact of AI-driven cytology in veterinary diagnostics. This course covers sample preparation and how the Vetscan Imagyst® system's AI Masses indication quickly identifies cancer-suggestive cells, helping veterinarians make timely treatment decisions and improve patient care.​
Program
Live Streaming: VMX Learning Theater West (Sunday)
CE Credit
0.5
Primary Discipline
Small Animal
Secondary Discipline
General
Learning Level
Intermediate
On-Demand
Not Available On-Demand
Manuscript
Manuscript NOT Available
RACE Credit Type
Medical
Zoetis1908As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.